Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)

Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated th...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular medicine Vol. 52; no. 2; p. 1
Main Authors Shao, Li-Hua, Zhu, Li, Wang, Meng, Ning, Yue, Chen, Feng-Qin, Gao, Xia-Qing, Yang, Chun-Ting, Wang, Hong-Wei, Li, Hai-Long
Format Journal Article
LanguageEnglish
Published Greece Spandidos Publications 01.08.2023
Spandidos Publications UK Ltd
D.A. Spandidos
Subjects
Amino acids
Apoptosis
Apoptosis - genetics
Autophagy
Autophagy - genetics
Breast cancer
Cancer
Cancer therapies
Care and treatment
Cell Death
Chemotherapy
Chromosomal proteins
Development and progression
DNA damage
Drug resistance
Drug resistance in microorganisms
Ferroptosis
Genes
Health aspects
HMGB1 Protein - genetics
Homeostasis
Humans
Immunotherapy
Inflammation
Leukemia
Liver cancer
Metastasis
Mitochondrial DNA
Multidrug resistant organisms
Natural products
Neoplasms - drug therapy
Neoplasms - genetics
Oncology, Experimental
Proteins
Review
RNA
Tumorigenesis
Tumors
Canada
China
pyroptosis
ferroptosis
nanoparticles
non‑coding RNA
tumor multidrug resistance
apoptosis and autophagy
high mobility group box 1
traditional Chinese medicine
Online AccessGet full text

Cover

Abstract Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated that HMGB1 functions as a 'double‑edged sword' that plays both pro‑ and anti‑tumor roles in the development and progression of multiple types of cancer. HMGB1 has also been found to be a key regulator of several cell death and signaling pathways, and is involved in MDR by mediating cell autophagy and apoptosis, ferroptosis, pyroptosis and multiple signaling pathways. Additionally, HMGB1 is regulated by a variety of non‑coding RNAs (ncRNAs), such as microRNAs, long ncRNAs and circular RNAs that are involved in MDR. Thus far, studies have been conducted to identify strategies with which to overcome HMGB1‑mediated MDR by the targeted silencing of HMGB1 and the targeted interference of HMGB1 expression using drugs and ncRNAs. Therefore, HMGB1 is closely associated with tumor MDR and is a promising therapeutic target.
AbstractList Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated that HMGB1 functions as a 'double‑edged sword' that plays both pro‑ and anti‑tumor roles in the development and progression of multiple types of cancer. HMGB1 has also been found to be a key regulator of several cell death and signaling pathways, and is involved in MDR by mediating cell autophagy and apoptosis, ferroptosis, pyroptosis and multiple signaling pathways. Additionally, HMGB1 is regulated by a variety of non‑coding RNAs (ncRNAs), such as microRNAs, long ncRNAs and circular RNAs that are involved in MDR. Thus far, studies have been conducted to identify strategies with which to overcome HMGB1‑mediated MDR by the targeted silencing of HMGB1 and the targeted interference of HMGB1 expression using drugs and ncRNAs. Therefore, HMGB1 is closely associated with tumor MDR and is a promising therapeutic target.
Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated that HMGB1 functions as a 'double-edged sword' that plays both pro- and anti-tumor roles in the development and progression of multiple types of cancer. HMGB1 has also been found to be a key regulator of several cell death and signaling pathways, and is involved in MDR by mediating cell autophagy and apoptosis, ferroptosis, pyroptosis and multiple signaling pathways. Additionally, HMGB1 is regulated by a variety of non-coding RNAs (ncRNAs), such as microRNAs, long ncRNAs and circular RNAs that are involved in MDR. Thus far, studies have been conducted to identify strategies with which to overcome HMGB1-mediated MDR by the targeted silencing of HMGB1 and the targeted interference of HMGB1 expression using drugs and ncRNAs. Therefore, HMGB1 is closely associated with tumor MDR and is a promising therapeutic target. Key words: tumor multidrug resistance, high mobility group box 1, apoptosis and autophagy, pyroptosis, ferroptosis, non-coding RNA, traditional Chinese medicine, nanoparticles
ArticleNumber 69
Audience Academic
Author Ning, Yue
Shao, Li-Hua
Zhu, Li
Wang, Meng
Wang, Hong-Wei
Gao, Xia-Qing
Li, Hai-Long
Chen, Feng-Qin
Yang, Chun-Ting
AuthorAffiliation 2 Emergency Department, Minda Hospital of Hubei Minzu University, Enshi, Hubei 445000
3 Department of Clinical Laboratory, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730050, P.R. China
4 Department of Geriatrics, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730050, P.R. China
1 Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000
AuthorAffiliation_xml – name: 4 Department of Geriatrics, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730050, P.R. China
– name: 3 Department of Clinical Laboratory, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730050, P.R. China
– name: 1 Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000
– name: 2 Emergency Department, Minda Hospital of Hubei Minzu University, Enshi, Hubei 445000
Author_xml – sequence: 1
  givenname: Li-Hua
  surname: Shao
  fullname: Shao, Li-Hua
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
– sequence: 2
  givenname: Li
  surname: Zhu
  fullname: Zhu, Li
  organization: Emergency Department, Minda Hospital of Hubei Minzu University, Enshi, Hubei 445000, P.R. China
– sequence: 3
  givenname: Meng
  surname: Wang
  fullname: Wang, Meng
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
– sequence: 4
  givenname: Yue
  surname: Ning
  fullname: Ning, Yue
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
– sequence: 5
  givenname: Feng-Qin
  surname: Chen
  fullname: Chen, Feng-Qin
  organization: Emergency Department, Minda Hospital of Hubei Minzu University, Enshi, Hubei 445000, P.R. China
– sequence: 6
  givenname: Xia-Qing
  surname: Gao
  fullname: Gao, Xia-Qing
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
– sequence: 7
  givenname: Chun-Ting
  surname: Yang
  fullname: Yang, Chun-Ting
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
– sequence: 8
  givenname: Hong-Wei
  surname: Wang
  fullname: Wang, Hong-Wei
  organization: Department of Clinical Laboratory, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730050, P.R. China
– sequence: 9
  givenname: Hai-Long
  surname: Li
  fullname: Li, Hai-Long
  organization: Department of Internal Medicine, First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37387415$$D View this record in MEDLINE/PubMed
BookMark eNptkc9rFTEQx4NU7A-9epQFL3rYZ35tkj1JW2wrtAhFwVvIy07ey2OT1GT3if-9WVqrQpnDDDPf-TLD5xgdxBQBodcEr5jq6Qe_C2FFMWWrjkr6DB0R2ZOWcv79oNYEy5bJThyi41J2GNOO9-oFOmSSKclJd4Rub8BuTfQllMbHfRr3MNSimbbQXN1cnpEmpGEezeRTbJJrpjmk3IR5nPyQ502TofgymWiheXcLew8_379Ez50ZC7x6yCfo28Wnr-dX7fWXy8_np9et5UpMbSep6PlglcWwlmvBOGXQESdB9MIOfGDAOXbEWaCSc0HdYA04TFS3pk527AR9vPe9m9cBBgtxymbUd9kHk3_pZLz-fxL9Vm_SXhNc_yd0cXj74JDTjxnKpHdpzrEeraniCiuhBP-r2pgRtI8uVTcbfLH6VArKpVAMV9XqCVWNAYK3FZrztf_Ugs2plAzu8XKC9cJWL2z1wlYvbOvCm3__fZT_gcl-A8zVoU4
CitedBy_id crossref_primary_10_3390_ijms25105424
Cites_doi 10.7150/thno.30578
10.1186/s12943-021-01475-8
10.1172/JCI91786
10.1038/s41576-019-0158-7
10.1002/ijc.33711
10.2147/JIR.S336626
10.1002/ijc.11016
10.1016/j.biopha.2021.111775
10.3390/ijms23169327
10.1007/s00109-020-01998-5
10.3109/10428194.2011.616962
10.1111/cas.14813
10.1038/s41392-020-00428-9
10.1002/iub.2215
10.1177/1758835920970850
10.1136/jitc-2020-001369
10.1016/j.jhep.2015.02.009
10.1016/j.yexcr.2018.03.025
10.1111/imr.12601
10.1007/s13577-017-0182-x
10.1016/j.lfs.2020.118065
10.3390/ijerph17197247
10.1186/1476-4598-13-234
10.1002/ctm2.577
10.1158/1078-0432.CCR-13-0495
10.1186/s12943-018-0898-6
10.1016/j.bbadis.2018.11.015
10.1371/journal.pone.0180844
10.1016/j.cell.2022.06.003
10.1186/s13045-020-00920-3
10.1007/s13402-019-00477-5
10.1038/s41598-020-75783-2
10.3389/fimmu.2022.973935
10.5483/BMBRep.2011.44.9.601
10.1186/s13046-019-1234-8
10.1186/s12967-022-03416-5
10.1095/biolreprod.108.070243
10.1038/s41568-020-0263-0
10.1186/s12951-021-01017-w
10.3389/fcell.2020.00828
10.1186/s13046-019-1328-3
10.4149/neo_2020_200610N620
10.1038/s41571-020-0341-y
10.1007/s00018-021-04054-8
10.1016/j.cell.2012.03.042
10.20892/j.issn.2095-3941.2019.0353
10.3390/ijms231810494
10.2147/CMAR.S244374
10.18632/oncotarget.10413
10.1016/j.drup.2019.100645
10.1111/febs.15876
10.1136/jitc-2020-001966
10.1039/D1FO03191K
10.1080/15384047.2015.1017691
10.1016/j.phrs.2021.105582
10.1186/s13045-020-00985-0
10.1016/j.phymed.2022.154083
10.1038/bjc.2017.434
10.1016/j.pharmthera.2018.09.007
10.1186/s13045-022-01260-0
10.1038/s41467-022-31218-2
10.1016/j.redox.2021.102143
10.1016/j.apsb.2019.11.009
10.3390/ijms21218253
10.1016/j.ejmech.2019.05.027
10.3892/etm.2021.10137
10.1016/j.biopha.2020.110703
10.1016/j.pharmthera.2018.11.011
10.1186/s13046-021-01897-8
10.1016/j.tranon.2017.03.003
10.5230/jgc.2021.21.e40
10.1016/j.biomaterials.2021.120716
10.1083/jcb.200911078
10.1016/j.trsl.2019.08.005
10.1038/s41419-022-04927-1
10.1016/j.celrep.2021.109419
10.1186/s13045-020-00950-x
10.1038/s41392-021-00507-5
10.1111/cas.15400
10.1038/onc.2010.261
10.3390/biom11121841
10.1155/2010/915234
10.1016/j.ccell.2019.04.002
10.1007/s11033-022-07989-8
10.3390/biom11101451
10.1038/s41419-019-1585-2
10.1016/j.jid.2016.01.031
10.1038/s41568-019-0149-1
10.1007/s00109-020-02011-9
10.1016/j.apsb.2021.08.012
10.1080/2162402X.2018.1438109
10.7150/ijbs.47203
10.1007/s12094-021-02716-4
10.1007/s10456-021-09819-0
10.1007/s00018-016-2194-1
10.1007/s00335-022-09963-y
10.1016/j.jep.2021.113783
10.1186/s12957-022-02500-w
10.1002/adma.201904197
10.3389/fonc.2020.561936
10.3390/cancers14061462
10.1080/15548627.2018.1501134
10.1186/s13020-022-00645-0
10.1038/s41419-019-1883-8
10.3389/fphar.2021.719694
10.1172/JCI99032
10.1016/j.arr.2012.10.004
10.1007/s12020-020-02417-y
10.3390/cells9071664
10.1038/s12276-022-00736-w
10.1080/21655979.2021.1971502
10.3390/ijms23147865
10.1200/JCO.18.02050
10.1002/cac2.12194
10.1111/j.1742-4658.2010.07919.x
10.1186/s12885-022-09675-1
10.1158/2159-8290.CD-19-0672
10.3389/fphar.2021.715824
10.1016/j.immuni.2018.08.016
10.3389/fcvm.2021.685434
10.1016/j.bcp.2003.12.013
10.1158/0008-5472.CAN-17-1318
10.1186/s13046-018-0883-3
10.3389/fcell.2022.996307
10.1186/s13046-021-02143-x
10.3390/ijms23052496
10.1002/hep.30666
10.1002/ptr.7385
10.1016/j.molcel.2007.06.017
10.1016/j.jep.2020.113302
10.1016/j.biopha.2018.11.057
10.1016/j.toxlet.2019.02.002
10.1016/j.drup.2020.100715
10.7150/ijbs.23542
10.1001/jamainternmed.2021.4804
10.1016/j.bbrc.2019.01.090
10.1155/2020/4751349
10.1186/s40425-019-0511-6
10.1038/srep15085
10.1016/j.bbagrm.2009.09.008
10.1038/s41467-020-20260-7
10.1016/j.jdermsci.2016.12.011
10.1080/15548627.2021.1901204
10.4161/auto.6.8.13367
10.1186/s12943-023-01732-y
10.1016/j.bbcan.2019.188310
10.1038/s41419-019-1441-4
10.1016/j.ymthe.2021.08.027
10.1002/anie.202010281
10.1038/s41420-021-00649-z
10.1080/14737159.2019.1665998
10.1158/0008-5472.CAN-19-3066
10.1016/j.jep.2016.05.055
10.1038/s41392-020-00274-9
10.1186/s12951-022-01635-y
10.1016/j.cmet.2014.01.014
10.1136/gutjnl-2021-324420
10.1002/mc.22944
10.1016/j.lfs.2021.120268
10.1038/onc.2012.49
10.15252/embj.2021108272
10.1038/s41419-021-04150-4
10.1016/j.ccell.2020.03.017
10.1038/s41401-020-0478-3
10.4161/15548627.2014.994400
10.1002/adma.202104779
10.1038/s41586-019-1730-1
10.1590/1414-431x20198657
10.1111/pin.12393
10.3390/cancers11070986
10.1007/s00441-016-2389-7
10.1615/JEnvironPatholToxicolOncol.2021037139
10.3724/abbs.2022023
10.1038/nrclinonc.2016.96
10.1038/s41568-018-0005-8
10.1186/s13046-021-02168-2
10.1038/s41467-020-18443-3
10.1016/j.biopha.2015.01.013
10.1186/s12943-021-01446-z
10.7150/thno.46903
10.1016/j.lfs.2022.120727
10.1038/s41392-022-00975-3
10.1016/j.canlet.2014.12.012
10.1038/s41392-021-00801-2
10.1007/s10456-008-9093-5
10.1007/s11010-020-04015-y
10.18632/aging.203145
10.1016/j.phrs.2022.106514
10.7150/thno.15584
10.3390/cancers11101580
ContentType Journal Article
Copyright COPYRIGHT 2023 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2023
Copyright: © Shao et al. 2023
Copyright_xml – notice: COPYRIGHT 2023 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2023
– notice: Copyright: © Shao et al. 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.3892/ijmm.2023.5272
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE

ProQuest One Academic Eastern Edition
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-244X
ExternalDocumentID A762476830
10_3892_ijmm_2023_5272
37387415
Genre Journal Article
GeographicLocations Canada
China
GeographicLocations_xml – name: China
– name: Canada
GrantInformation_xml – fundername: Guiding Projects of the Enshi Tujia and Miao Autonomous Prefecture Science and Technology Plan of Hubei Province
  grantid: E20220033
– fundername: National Natural Science Foundation of Gansu Province
  grantid: 21JR7RA579
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
---
0R~
2WC
3V.
53G
5GY
7X7
88E
8AO
8FI
8FJ
AAYXX
ABJNI
ABUWG
ACGFO
ACGFS
ADBBV
AEGXH
AENEX
AFKRA
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMOBN
F5P
FRP
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
INH
INR
IPNFZ
ITC
M1P
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
RIG
SV3
TEORI
TR2
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c486t-572694dc8c0eb7b63423e51f7e696cd4d3e440f1fce274462fdcaef0185b2f753
IEDL.DBID 7X7
ISSN 1107-3756
IngestDate Tue Sep 17 21:31:07 EDT 2024
Thu Oct 10 19:33:47 EDT 2024
Thu Feb 22 23:29:24 EST 2024
Wed Nov 13 00:06:01 EST 2024
Fri Aug 23 00:58:59 EDT 2024
Wed Oct 16 00:39:16 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords pyroptosis
ferroptosis
nanoparticles
non‑coding RNA
tumor multidrug resistance
apoptosis and autophagy
high mobility group box 1
traditional Chinese medicine
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c486t-572694dc8c0eb7b63423e51f7e696cd4d3e440f1fce274462fdcaef0185b2f753
Notes Contributed equally
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC10373125
PMID 37387415
PQID 2848086864
PQPubID 2044958
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10373125
proquest_journals_2848086864
gale_infotracmisc_A762476830
gale_infotracacademiconefile_A762476830
crossref_primary_10_3892_ijmm_2023_5272
pubmed_primary_37387415
PublicationCentury 2000
PublicationDate 2023-08-01
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle International journal of molecular medicine
PublicationTitleAlternate Int J Mol Med
PublicationYear 2023
Publisher Spandidos Publications
Spandidos Publications UK Ltd
D.A. Spandidos
Publisher_xml – name: Spandidos Publications
– name: Spandidos Publications UK Ltd
– name: D.A. Spandidos
References Kang (key20230810105114_b49-ijmm-52-2-05272) 2013; 19
Tang (key20230810105114_b125-ijmm-52-2-05272) 2020; 257
Yasinska (key20230810105114_b64-ijmm-52-2-05272) 2018; 7
Sur (key20230810105114_b146-ijmm-52-2-05272) 2022; 289
Lee (key20230810105114_b120-ijmm-52-2-05272) 2020; 10
Wei (key20230810105114_b169-ijmm-52-2-05272) 2022; 24
Zhu (key20230810105114_b147-ijmm-52-2-05272) 2019; 10
Liang (key20230810105114_b60-ijmm-52-2-05272) 2020; 10
Voong (key20230810105114_b30-ijmm-52-2-05272) 2021; 11
van Beijnum (key20230810105114_b73-ijmm-52-2-05272) 2013; 32
Gong (key20230810105114_b45-ijmm-52-2-05272) 2010; 2010
Liu (key20230810105114_b65-ijmm-52-2-05272) 2021; 99
Zhou (key20230810105114_b81-ijmm-52-2-05272) 2015; 5
Jolly (key20230810105114_b1-ijmm-52-2-05272) 2019; 194
Vasan (key20230810105114_b6-ijmm-52-2-05272) 2019; 575
Shi (key20230810105114_b95-ijmm-52-2-05272) 2019; 52
Hassannia (key20230810105114_b107-ijmm-52-2-05272) 2019; 35
Zhai (key20230810105114_b20-ijmm-52-2-05272) 2021; 11
Yang (key20230810105114_b166-ijmm-52-2-05272) 2012; 53
Borde (key20230810105114_b26-ijmm-52-2-05272) 2022; 23
Pal Singh (key20230810105114_b89-ijmm-52-2-05272) 2020; 21
Yan (key20230810105114_b176-ijmm-52-2-05272) 2021; 13
Bianchi (key20230810105114_b34-ijmm-52-2-05272) 2017; 280
Wang (key20230810105114_b110-ijmm-52-2-05272) 2022; 13
Jiang (key20230810105114_b51-ijmm-52-2-05272) 2018; 367
Xi (key20230810105114_b172-ijmm-52-2-05272) 2021; 12
Wiernicki (key20230810105114_b113-ijmm-52-2-05272) 2022; 13
Erkes (key20230810105114_b136-ijmm-52-2-05272) 2020; 10
Yuan (key20230810105114_b63-ijmm-52-2-05272) 2020; 13
Liu (key20230810105114_b59-ijmm-52-2-05272) 2015; 63
Sharma (key20230810105114_b77-ijmm-52-2-05272) 2016; 365
Chen (key20230810105114_b111-ijmm-52-2-05272) 2022; 54
Gao (key20230810105114_b56-ijmm-52-2-05272) 2019; 7
Jenkins (key20230810105114_b3-ijmm-52-2-05272) 2018; 118
Li (key20230810105114_b175-ijmm-52-2-05272) 2020; 2020
Hassannia (key20230810105114_b190-ijmm-52-2-05272) 2018; 128
Liu (key20230810105114_b167-ijmm-52-2-05272) 2021; 99
Wu (key20230810105114_b71-ijmm-52-2-05272) 2018; 2018
Díaz-Martínez (key20230810105114_b145-ijmm-52-2-05272) 2018; 78
Zhou (key20230810105114_b72-ijmm-52-2-05272) 2021; 25
Amornsupak (key20230810105114_b50-ijmm-52-2-05272) 2022; 22
He (key20230810105114_b142-ijmm-52-2-05272) 2020; 16
Singh (key20230810105114_b153-ijmm-52-2-05272) 2021; 20
Catena (key20230810105114_b31-ijmm-52-2-05272) 2009; 80
Li (key20230810105114_b151-ijmm-52-2-05272) 2021; 40
Sosa (key20230810105114_b109-ijmm-52-2-05272) 2013; 12
Guo (key20230810105114_b25-ijmm-52-2-05272) 2018; 37
Wang (key20230810105114_b68-ijmm-52-2-05272) 2020; 10
Rapoport (key20230810105114_b48-ijmm-52-2-05272) 2020; 9
Wu (key20230810105114_b128-ijmm-52-2-05272) 2022; 13
Mou (key20230810105114_b98-ijmm-52-2-05272) 2017; 85
Wang (key20230810105114_b178-ijmm-52-2-05272) 2021; 270
Ye (key20230810105114_b58-ijmm-52-2-05272) 2019; 9
Wen (key20230810105114_b29-ijmm-52-2-05272) 2021; 476
Zhu (key20230810105114_b75-ijmm-52-2-05272) 2015; 357
Chaudhary (key20230810105114_b118-ijmm-52-2-05272) 2021; 149
Xi (key20230810105114_b170-ijmm-52-2-05272) 2016; 190
Wang (key20230810105114_b22-ijmm-52-2-05272) 2022; 13
Meng (key20230810105114_b193-ijmm-52-2-05272) 2021; 41
Wu (key20230810105114_b121-ijmm-52-2-05272) 2021; 60
Wei (key20230810105114_b168-ijmm-52-2-05272) 2022; 17
Zhang (key20230810105114_b116-ijmm-52-2-05272) 2021; 8
Hernandez (key20230810105114_b52-ijmm-52-2-05272) 2018; 128
Wang (key20230810105114_b46-ijmm-52-2-05272) 2020; 13
Taniguchi (key20230810105114_b33-ijmm-52-2-05272) 2018; 31
Lei (key20230810105114_b158-ijmm-52-2-05272) 2022; 54
Li (key20230810105114_b99-ijmm-52-2-05272) 2019; 9
Xie (key20230810105114_b10-ijmm-52-2-05272) 2022; 186
He (key20230810105114_b21-ijmm-52-2-05272) 2022; 15
Schoenfeld (key20230810105114_b8-ijmm-52-2-05272) 2020; 37
Carneiro (key20230810105114_b15-ijmm-52-2-05272) 2020; 17
Lee (key20230810105114_b62-ijmm-52-2-05272) 2016; 66
LeClair (key20230810105114_b157-ijmm-52-2-05272) 2021; 181
Niu (key20230810105114_b32-ijmm-52-2-05272) 2020; 12
Erin (key20230810105114_b12-ijmm-52-2-05272) 2020; 53
Kim (key20230810105114_b86-ijmm-52-2-05272) 2004; 67
Kam (key20230810105114_b44-ijmm-52-2-05272) 2022; 25
Aleksakhina (key20230810105114_b9-ijmm-52-2-05272) 2019; 1872
Efimova (key20230810105114_b114-ijmm-52-2-05272) 2020; 8
Wu (key20230810105114_b187-ijmm-52-2-05272) 2016; 7
Wang (key20230810105114_b127-ijmm-52-2-05272) 2018; 14
Ren (key20230810105114_b150-ijmm-52-2-05272) 2022; 33
Hou (key20230810105114_b133-ijmm-52-2-05272) 2021; 14
Ge (key20230810105114_b84-ijmm-52-2-05272) 2016; 136
Çoku (key20230810105114_b87-ijmm-52-2-05272) 2022; 41
Wen (key20230810105114_b112-ijmm-52-2-05272) 2019; 510
Yan (key20230810105114_b106-ijmm-52-2-05272) 2021; 6
Li Pomi (key20230810105114_b55-ijmm-52-2-05272) 2022; 23
Stockwell (key20230810105114_b108-ijmm-52-2-05272) 2022; 185
Xie (key20230810105114_b188-ijmm-52-2-05272) 2023; 22
Zhang (key20230810105114_b57-ijmm-52-2-05272) 2018; 17
Ngamcherdtrakul (key20230810105114_b183-ijmm-52-2-05272) 2019; 214
Wei (key20230810105114_b179-ijmm-52-2-05272) 2022; 100
Assaraf (key20230810105114_b7-ijmm-52-2-05272) 2019; 46
Gialeli (key20230810105114_b78-ijmm-52-2-05272) 2011; 278
Yu (key20230810105114_b181-ijmm-52-2-05272) 2019; 196
Chen (key20230810105114_b101-ijmm-52-2-05272) 2022; 36
Yao (key20230810105114_b80-ijmm-52-2-05272) 2015; 70
Liao (key20230810105114_b82-ijmm-52-2-05272) 2022; 15
Zhang (key20230810105114_b96-ijmm-52-2-05272) 2021; 40
Pu (key20230810105114_b163-ijmm-52-2-05272) 2022; 20
Gourley (key20230810105114_b13-ijmm-52-2-05272) 2019; 37
Stros (key20230810105114_b28-ijmm-52-2-05272) 2010; 1799
Tan (key20230810105114_b54-ijmm-52-2-05272) 2020; 13
Barth (key20230810105114_b140-ijmm-52-2-05272) 2019; 11
Zhang (key20230810105114_b156-ijmm-52-2-05272) 2017; 10
Ming (key20230810105114_b174-ijmm-52-2-05272) 2021; 265
Phan (key20230810105114_b2-ijmm-52-2-05272) 2020; 20
Tang (key20230810105114_b92-ijmm-52-2-05272) 2010; 29
Dixon (key20230810105114_b103-ijmm-52-2-05272) 2012; 149
Hage (key20230810105114_b123-ijmm-52-2-05272) 2019; 70
Robey (key20230810105114_b18-ijmm-52-2-05272) 2018; 18
Cheng (key20230810105114_b35-ijmm-52-2-05272) 2020; 43
Gaikwad (key20230810105114_b27-ijmm-52-2-05272) 2021; 36
Ferreira (key20230810105114_b85-ijmm-52-2-05272) 2021; 168
Yu (key20230810105114_b129-ijmm-52-2-05272) 2021; 6
Huebener (key20230810105114_b47-ijmm-52-2-05272) 2014; 19
Wu (key20230810105114_b124-ijmm-52-2-05272) 2020; 12
Liu (key20230810105114_b36-ijmm-52-2-05272) 2021; 13
Ren (key20230810105114_b160-ijmm-52-2-05272) 2021; 12
Wilczyński (key20230810105114_b5-ijmm-52-2-05272) 2022; 23
Xia (key20230810105114_b130-ijmm-52-2-05272) 2019; 10
Majidinia (key20230810105114_b24-ijmm-52-2-05272) 2020; 72
Luo (key20230810105114_b102-ijmm-52-2-05272) 2018; 14
Zhao (key20230810105114_b66-ijmm-52-2-05272) 2011; 44
Li (key20230810105114_b155-ijmm-52-2-05272) 2022; 30
Chioccarelli (key20230810105114_b152-ijmm-52-2-05272) 2021; 79
Barth (key20230810105114_b138-ijmm-52-2-05272) 2020; 8
Volchuk (key20230810105114_b131-ijmm-52-2-05272) 2020; 11
Tang (key20230810105114_b91-ijmm-52-2-05272) 2010; 190
Sharma (key20230810105114_b184-ijmm-52-2-05272) 2022; 304
Grimson (key20230810105114_b141-ijmm-52-2-05272) 2007; 27
Zhang (key20230810105114_b164-ijmm-52-2-05272) 2022; 49
Liu (key20230810105114_b100-ijmm-52-2-05272) 2015; 16
Peng (key20230810105114_b134-ijmm-52-2-05272) 2020; 5
Wang (key20230810105114_b43-ijmm-52-2-05272) 2020; 11
Zeuschner (key20230810105114_b139-ijmm-52-2-05272) 2020; 20
Chen (key20230810105114_b177-ijmm-52-2-05272) 2019; 38
Tang (key20230810105114_b90-ijmm-52-2-05272) 2010; 6
Hubert (key20230810105114_b40-ijmm-52-2-05272) 2021; 9
Taheri (key20230810105114_b143-ijmm-52-2-05272) 2020; 131
Kishi (key20230810105114_b159-ijmm-52-2-05272) 2022; 113
Liu (key20230810105114_b189-ijmm-52-2-05272) 2022; 10
Kumar (key20230810105114_b16-ijmm-52-2-05272) 2019; 176
Qi (key20230810105114_b122-ijmm-52-2-05272) 2022; 23
Run (key20230810105114_b97-ijmm-52-2-05272) 2021; 71
Chen (key20230810105114_b154-ijmm-52-2-05272) 2021; 20
Mukherjee (key20230810105114_b186-ijmm-52-2-05272) 2020; 80
Lopez (key20230810105114_b4-ijmm-52-2-05272) 2017; 14
Tilaoui (key20230810105114_b23-ijmm-52-2-05272) 2021; 12
Chou (key20230810105114_b42-ijmm-52-2-05272) 2020; 17
Yu (key20230810105114_b126-ijmm-52-2-05272) 2019; 10
Zhou (key20230810105114_b162-ijmm-52-2-05272) 2021; 21
Lai (key20230810105114_b17-ijmm-52-2-05272) 2020; 10
Chen (key20230810105114_b61-ijmm-52-2-05272) 2021; 68
Vats (key20230810105114_b115-ijmm-52-2-05272) 2021; 47
Chen (key20230810105114_b19-ijmm-52-2-05272) 2021; 11
Zha (key20230810105114_b41-ijmm-52-2-05272) 2020; 17
Kuniyasu (key20230810105114_b76-ijmm-52-2-05272) 2003; 104
Wei (key20230810105114_b37-ijmm-52-2-05272) 2021; 6
Xu (key20230810105114_b165-ijmm-52-2-05272) 2021; 19
Wang (key20230810105114_b171-ijmm-52-2-05272) 2021; 140
Yang (key20230810105114_b88-ijmm-52-2-05272) 2015; 11
Zhao (key20230810105114_b39-ijmm-52-2-05272) 2021; 40
van Beijnum (key20230810105114_b74-ijmm-52-2-05272) 2008; 11
Jiang (key20230810105114_b194-ijmm-52-2-05272) 2021; 33
Luo (key20230810105114_b148-ijmm-52-2-05272) 2021; 17
Qian (key20230810105114_b69-ijmm-52-2-05272) 2019; 58
Chai (key20230810105114_b38-ijmm-52-2-05272) 2019; 38
Liang (key20230810105114_b105-ijmm-52-2-05272) 2019; 31
Makena (key20230810105114_b11-ijmm-52-2-05272) 2020; 1866
Sharma (key20230810105114_b185-ijmm-52-2-05272) 2022; 291
Deng (key20230810105114_b132-ijmm-52-2-05272) 2018; 49
Sundar (key20230810105114_b14-ijmm-52-2-05272) 2022; 71
Singh (key20230810105114_b93-ijmm-52-2-05272) 2019; 11
You (key20230810105114_b119-ijmm-52-2-05272) 2021; 40
Kristensen (key20230810105114_b182-ijmm-52-2-05272) 2019; 20
Ding (key20230810105114_b67-ijmm-52-2-05272) 2019; 110
Roy (key20230810105114_b180-ijmm-52-2-05272) 2016; 6
Kim (key20230810105114_b191-ijmm-52-2-05272) 2022; 20
Friedmann Angeli (key20230810105114_b117-ijmm-52-2-05272) 2019; 19
Liu (key20230810105114_b79-ijmm-52-2-05272) 2017; 12
Shi (key20230810105114_b94-ijmm-52-2-05272) 2019; 306
Zhang (key20230810105114_b53-ijmm-52-
References_xml – volume: 9
  start-page: 1909
  year: 2019
  ident: key20230810105114_b99-ijmm-52-2-05272
  article-title: HMGB1-induced p62 overexpression promotes snail-mediated epithelial-mesenchymal transition in glioblastoma cells via the degradation of GSK-3β
  publication-title: Theranostics
  doi: 10.7150/thno.30578
  contributor:
    fullname: Li
– volume: 20
  start-page: 166
  year: 2021
  ident: key20230810105114_b154-ijmm-52-2-05272
  article-title: The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01475-8
  contributor:
    fullname: Chen
– volume: 128
  start-page: 2436
  year: 2018
  ident: key20230810105114_b52-ijmm-52-2-05272
  article-title: HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI91786
  contributor:
    fullname: Hernandez
– volume: 2018
  start-page: 3453706
  year: 2018
  ident: key20230810105114_b71-ijmm-52-2-05272
  article-title: High mobility group box Protein 1 serves as a potential prognostic marker of lung cancer and promotes its invasion and metastasis by matrix Metalloproteinase-2 in a nuclear Factor-κB-dependent manner
  publication-title: Biomed Res Int
  contributor:
    fullname: Wu
– volume: 20
  start-page: 675
  year: 2019
  ident: key20230810105114_b182-ijmm-52-2-05272
  article-title: The biogenesis, biology and characterization of circular RNAs
  publication-title: Nat Rev Genet
  doi: 10.1038/s41576-019-0158-7
  contributor:
    fullname: Kristensen
– volume: 149
  start-page: 1495
  year: 2021
  ident: key20230810105114_b118-ijmm-52-2-05272
  article-title: Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer
  publication-title: Int J Cancer
  doi: 10.1002/ijc.33711
  contributor:
    fullname: Chaudhary
– volume: 14
  start-page: 7295
  year: 2021
  ident: key20230810105114_b133-ijmm-52-2-05272
  article-title: HMGB1-induced hepatocyte pyroptosis expanding inflammatory responses contributes to the pathogenesis of Acute-on-chronic liver failure (ACLF)
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S336626
  contributor:
    fullname: Hou
– volume: 104
  start-page: 722
  year: 2003
  ident: key20230810105114_b76-ijmm-52-2-05272
  article-title: Differential effects between amphoterin and advanced glycation end products on colon cancer cells
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11016
  contributor:
    fullname: Kuniyasu
– volume: 140
  start-page: 111775
  year: 2021
  ident: key20230810105114_b171-ijmm-52-2-05272
  article-title: Shengbai decoction enhances the anti-tumor efficacy of cyclophosphamide on hepatoma 22-bearing mice
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.111775
  contributor:
    fullname: Wang
– volume: 23
  start-page: 9327
  year: 2022
  ident: key20230810105114_b55-ijmm-52-2-05272
  article-title: Role of HMGB1 in Cutaneous Melanoma: State of the Art
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23169327
  contributor:
    fullname: Li Pomi
– volume: 99
  start-page: 107
  year: 2021
  ident: key20230810105114_b65-ijmm-52-2-05272
  article-title: HMGB1: An important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-020-01998-5
  contributor:
    fullname: Liu
– volume: 53
  start-page: 315
  year: 2012
  ident: key20230810105114_b166-ijmm-52-2-05272
  article-title: Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428194.2011.616962
  contributor:
    fullname: Yang
– volume: 9
  start-page: 730
  year: 2019
  ident: key20230810105114_b58-ijmm-52-2-05272
  article-title: HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRAS(Q61L) cells
  publication-title: Am J Cancer Res
  contributor:
    fullname: Ye
– volume: 112
  start-page: 1603
  year: 2021
  ident: key20230810105114_b53-ijmm-52-2-05272
  article-title: HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer
  publication-title: Cancer Sci
  doi: 10.1111/cas.14813
  contributor:
    fullname: Zhang
– volume: 6
  start-page: 49
  year: 2021
  ident: key20230810105114_b106-ijmm-52-2-05272
  article-title: Ferroptosis: Mechanisms and links with diseases
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-00428-9
  contributor:
    fullname: Yan
– volume: 72
  start-page: 855
  year: 2020
  ident: key20230810105114_b24-ijmm-52-2-05272
  article-title: Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
  publication-title: IUBMB Life
  doi: 10.1002/iub.2215
  contributor:
    fullname: Majidinia
– volume: 12
  start-page: 1758835920970850
  year: 2020
  ident: key20230810105114_b32-ijmm-52-2-05272
  article-title: Biological functions and theranostic potential of HMGB family members in human cancers
  publication-title: Ther Adv Med Oncol
  doi: 10.1177/1758835920970850
  contributor:
    fullname: Niu
– volume: 8
  start-page: e001369
  year: 2020
  ident: key20230810105114_b114-ijmm-52-2-05272
  article-title: Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2020-001369
  contributor:
    fullname: Efimova
– volume: 63
  start-page: 114
  year: 2015
  ident: key20230810105114_b59-ijmm-52-2-05272
  article-title: Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2015.02.009
  contributor:
    fullname: Liu
– volume: 367
  start-page: 81
  year: 2018
  ident: key20230810105114_b51-ijmm-52-2-05272
  article-title: Hypoxia-induced HMGB1 expression of HCC promotes tumor invasiveness and metastasis via regulating macrophage-derived IL-6
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2018.03.025
  contributor:
    fullname: Jiang
– volume: 280
  start-page: 74
  year: 2017
  ident: key20230810105114_b34-ijmm-52-2-05272
  article-title: High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
  publication-title: Immunol Rev
  doi: 10.1111/imr.12601
  contributor:
    fullname: Bianchi
– volume: 31
  start-page: 1
  year: 2018
  ident: key20230810105114_b33-ijmm-52-2-05272
  article-title: HMGB proteins and arthritis
  publication-title: Hum Cell
  doi: 10.1007/s13577-017-0182-x
  contributor:
    fullname: Taniguchi
– volume: 257
  start-page: 118065
  year: 2020
  ident: key20230810105114_b125-ijmm-52-2-05272
  article-title: Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118065
  contributor:
    fullname: Tang
– volume: 17
  start-page: 1332
  year: 2020
  ident: key20230810105114_b42-ijmm-52-2-05272
  article-title: The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph17197247
  contributor:
    fullname: Chou
– volume: 13
  start-page: 234
  year: 2014
  ident: key20230810105114_b144-ijmm-52-2-05272
  article-title: miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-234
  contributor:
    fullname: Deng
– volume: 11
  start-page: e577
  year: 2021
  ident: key20230810105114_b19-ijmm-52-2-05272
  article-title: Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.577
  contributor:
    fullname: Chen
– volume: 19
  start-page: 4046
  year: 2013
  ident: key20230810105114_b49-ijmm-52-2-05272
  article-title: HMGB1 in cancer: Good, bad, or both?
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-0495
  contributor:
    fullname: Kang
– volume: 17
  start-page: 146
  year: 2018
  ident: key20230810105114_b57-ijmm-52-2-05272
  article-title: Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0898-6
  contributor:
    fullname: Zhang
– volume: 1866
  start-page: 165339
  year: 2020
  ident: key20230810105114_b11-ijmm-52-2-05272
  article-title: Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance
  publication-title: Biochim Biophys Acta Mol Basis Dis
  doi: 10.1016/j.bbadis.2018.11.015
  contributor:
    fullname: Makena
– volume: 12
  start-page: e0180844
  year: 2017
  ident: key20230810105114_b79-ijmm-52-2-05272
  article-title: MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0180844
  contributor:
    fullname: Liu
– volume: 13
  start-page: 10127
  year: 2021
  ident: key20230810105114_b176-ijmm-52-2-05272
  article-title: Baicalin inhibits LPS-induced inflammation in RAW264.7 cells through miR-181b/HMGB1/TRL4/NF-κB pathway
  publication-title: Am J Transl Res
  contributor:
    fullname: Yan
– volume: 185
  start-page: 2401
  year: 2022
  ident: key20230810105114_b108-ijmm-52-2-05272
  article-title: Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
  publication-title: Cell
  doi: 10.1016/j.cell.2022.06.003
  contributor:
    fullname: Stockwell
– volume: 13
  start-page: 91
  year: 2020
  ident: key20230810105114_b63-ijmm-52-2-05272
  article-title: High mobility group box 1 (HMGB1): A pivotal regulator of hematopoietic malignancies
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-00920-3
  contributor:
    fullname: Yuan
– volume: 43
  start-page: 177
  year: 2020
  ident: key20230810105114_b35-ijmm-52-2-05272
  article-title: HMGB1: An overview of its versatile roles in the pathogenesis of colorectal cancer
  publication-title: Cell Oncol (Dordr)
  doi: 10.1007/s13402-019-00477-5
  contributor:
    fullname: Cheng
– volume: 10
  start-page: 18587
  year: 2020
  ident: key20230810105114_b68-ijmm-52-2-05272
  article-title: Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-75783-2
  contributor:
    fullname: Wang
– volume: 13
  start-page: 973935
  year: 2022
  ident: key20230810105114_b128-ijmm-52-2-05272
  article-title: The role of pyroptosis and its crosstalk with immune therapy in breast cancer
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.973935
  contributor:
    fullname: Wu
– volume: 44
  start-page: 601
  year: 2011
  ident: key20230810105114_b66-ijmm-52-2-05272
  article-title: HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells
  publication-title: BMB Rep
  doi: 10.5483/BMBRep.2011.44.9.601
  contributor:
    fullname: Zhao
– volume: 38
  start-page: 254
  year: 2019
  ident: key20230810105114_b177-ijmm-52-2-05272
  article-title: Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1234-8
  contributor:
    fullname: Chen
– volume: 20
  start-page: 212
  year: 2022
  ident: key20230810105114_b163-ijmm-52-2-05272
  article-title: VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
  publication-title: J Transl Med
  doi: 10.1186/s12967-022-03416-5
  contributor:
    fullname: Pu
– volume: 80
  start-page: 358
  year: 2009
  ident: key20230810105114_b31-ijmm-52-2-05272
  article-title: HMGB4, a novel member of the HMGB family, is preferentially expressed in the mouse testis and localizes to the basal pole of elongating spermatids
  publication-title: Biol Reprod
  doi: 10.1095/biolreprod.108.070243
  contributor:
    fullname: Catena
– volume: 20
  start-page: 398
  year: 2020
  ident: key20230810105114_b2-ijmm-52-2-05272
  article-title: The dormant cancer cell life cycle
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-0263-0
  contributor:
    fullname: Phan
– volume: 19
  start-page: 268
  year: 2021
  ident: key20230810105114_b165-ijmm-52-2-05272
  article-title: Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
  publication-title: J Nanobiotechnol
  doi: 10.1186/s12951-021-01017-w
  contributor:
    fullname: Xu
– volume: 8
  start-page: 828
  year: 2020
  ident: key20230810105114_b138-ijmm-52-2-05272
  article-title: Circulating Non-coding RNAs in renal cell carcinoma-pathogenesis and potential implications as clinical biomarkers
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2020.00828
  contributor:
    fullname: Barth
– volume: 38
  start-page: 325
  year: 2019
  ident: key20230810105114_b38-ijmm-52-2-05272
  article-title: HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1328-3
  contributor:
    fullname: Chai
– volume: 68
  start-page: 71
  year: 2021
  ident: key20230810105114_b61-ijmm-52-2-05272
  article-title: HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_200610N620
  contributor:
    fullname: Chen
– volume: 17
  start-page: 395
  year: 2020
  ident: key20230810105114_b15-ijmm-52-2-05272
  article-title: Targeting apoptosis in cancer therapy
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-0341-y
  contributor:
    fullname: Carneiro
– volume: 79
  start-page: 50
  year: 2021
  ident: key20230810105114_b152-ijmm-52-2-05272
  article-title: FUS driven circCNOT6L biogenesis in mouse and human spermatozoa supports zygote development
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-021-04054-8
  contributor:
    fullname: Chioccarelli
– volume: 149
  start-page: 1060
  year: 2012
  ident: key20230810105114_b103-ijmm-52-2-05272
  article-title: Ferroptosis: An iron-dependent form of nonapoptotic cell death
  publication-title: Cell
  doi: 10.1016/j.cell.2012.03.042
  contributor:
    fullname: Dixon
– volume: 17
  start-page: 154
  year: 2020
  ident: key20230810105114_b41-ijmm-52-2-05272
  article-title: Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
  publication-title: Cancer Biol Med
  doi: 10.20892/j.issn.2095-3941.2019.0353
  contributor:
    fullname: Zha
– volume: 23
  start-page: 10494
  year: 2022
  ident: key20230810105114_b122-ijmm-52-2-05272
  article-title: Pyroptosis and its role in the modulation of cancer progression and antitumor immunity
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms231810494
  contributor:
    fullname: Qi
– volume: 12
  start-page: 10397
  year: 2020
  ident: key20230810105114_b124-ijmm-52-2-05272
  article-title: LPS enhances the chemosensitivity of oxaliplatin in HT29 cells via GSDMD-mediated pyroptosis
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S244374
  contributor:
    fullname: Wu
– volume: 7
  start-page: 50417
  year: 2016
  ident: key20230810105114_b187-ijmm-52-2-05272
  article-title: HMGB1 overexpression as a prognostic factor for survival in cancer: A meta-analysis and systematic review
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.10413
  contributor:
    fullname: Wu
– volume: 46
  start-page: 100645
  year: 2019
  ident: key20230810105114_b7-ijmm-52-2-05272
  article-title: The multi-factorial nature of clinical multidrug resistance in cancer
  publication-title: Drug Resist Updat
  doi: 10.1016/j.drup.2019.100645
  contributor:
    fullname: Assaraf
– volume: 289
  start-page: 3011
  year: 2022
  ident: key20230810105114_b146-ijmm-52-2-05272
  article-title: Emerging role of lncRNA ELDR in development and cancer
  publication-title: FEBS J
  doi: 10.1111/febs.15876
  contributor:
    fullname: Sur
– volume: 9
  start-page: e001966
  year: 2021
  ident: key20230810105114_b40-ijmm-52-2-05272
  article-title: Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2020-001966
  contributor:
    fullname: Hubert
– volume: 13
  start-page: 2200
  year: 2022
  ident: key20230810105114_b22-ijmm-52-2-05272
  article-title: S-20, a steroidal saponin from the berries of black nightshade, exerts anti-multidrug resistance activity in K562/ADR cells through autophagic cell death and ERK activation
  publication-title: Food Funct
  doi: 10.1039/D1FO03191K
  contributor:
    fullname: Wang
– volume: 16
  start-page: 511
  year: 2015
  ident: key20230810105114_b100-ijmm-52-2-05272
  article-title: HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
  publication-title: Cancer Biol Ther
  doi: 10.1080/15384047.2015.1017691
  contributor:
    fullname: Liu
– volume: 168
  start-page: 105582
  year: 2021
  ident: key20230810105114_b85-ijmm-52-2-05272
  article-title: Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2021.105582
  contributor:
    fullname: Ferreira
– volume: 13
  start-page: 149
  year: 2020
  ident: key20230810105114_b54-ijmm-52-2-05272
  article-title: HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-00985-0
  contributor:
    fullname: Tan
– volume: 100
  start-page: 154083
  year: 2022
  ident: key20230810105114_b179-ijmm-52-2-05272
  article-title: Gegen Qinlian pills alleviate carrageenan-induced thrombosis in mice model by regulating the HMGB1/NF-κB/NLRP3 signaling
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2022.154083
  contributor:
    fullname: Wei
– volume: 118
  start-page: 9
  year: 2018
  ident: key20230810105114_b3-ijmm-52-2-05272
  article-title: Mechanisms of resistance to immune checkpoint inhibitors
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2017.434
  contributor:
    fullname: Jenkins
– volume: 194
  start-page: 161
  year: 2019
  ident: key20230810105114_b1-ijmm-52-2-05272
  article-title: Hybrid Epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2018.09.007
  contributor:
    fullname: Jolly
– volume: 15
  start-page: 44
  year: 2022
  ident: key20230810105114_b82-ijmm-52-2-05272
  article-title: Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: A revisited perspective from molecular mechanisms to targeted therapies
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-022-01260-0
  contributor:
    fullname: Liao
– volume: 13
  start-page: 3676
  year: 2022
  ident: key20230810105114_b113-ijmm-52-2-05272
  article-title: Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-31218-2
  contributor:
    fullname: Wiernicki
– volume: 47
  start-page: 102143
  year: 2021
  ident: key20230810105114_b115-ijmm-52-2-05272
  article-title: Keratinocyte death by ferroptosis initiates skin inflammation after UVB exposure
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2021.102143
  contributor:
    fullname: Vats
– volume: 10
  start-page: 1036
  year: 2020
  ident: key20230810105114_b60-ijmm-52-2-05272
  article-title: MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2019.11.009
  contributor:
    fullname: Liang
– volume: 21
  start-page: 8253
  year: 2020
  ident: key20230810105114_b89-ijmm-52-2-05272
  article-title: Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21218253
  contributor:
    fullname: Pal Singh
– volume: 176
  start-page: 268
  year: 2019
  ident: key20230810105114_b16-ijmm-52-2-05272
  article-title: Natural products as multidrug resistance modulators in cancer
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2019.05.027
  contributor:
    fullname: Kumar
– volume: 22
  start-page: 705
  year: 2021
  ident: key20230810105114_b161-ijmm-52-2-05272
  article-title: HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2021.10137
  contributor:
    fullname: Ning
– volume: 131
  start-page: 110703
  year: 2020
  ident: key20230810105114_b143-ijmm-52-2-05272
  article-title: Expression profile of microRNAs in bladder cancer and their application as biomarkers
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110703
  contributor:
    fullname: Taheri
– volume: 196
  start-page: 91
  year: 2019
  ident: key20230810105114_b181-ijmm-52-2-05272
  article-title: RNA therapy: Are we using the right molecules?
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2018.11.011
  contributor:
    fullname: Yu
– volume: 40
  start-page: 99
  year: 2021
  ident: key20230810105114_b39-ijmm-52-2-05272
  article-title: YAP promotes autophagy and progression of gliomas via upregulating HMGB1
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-01897-8
  contributor:
    fullname: Zhao
– volume: 10
  start-page: 410
  year: 2017
  ident: key20230810105114_b156-ijmm-52-2-05272
  article-title: Upregulation of miR-142-3p improves drug sensitivity of acute myelogenous leukemia through reducing P-glycoprotein and repressing autophagy by targeting HMGB1
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2017.03.003
  contributor:
    fullname: Zhang
– volume: 21
  start-page: 439
  year: 2021
  ident: key20230810105114_b162-ijmm-52-2-05272
  article-title: Vitexin inhibits gastric cancer growth and metastasis through HMGB1-mediated inactivation of the PI3K/AKT/mTOR/HIF-1α signaling pathway
  publication-title: J Gastric Cancer
  doi: 10.5230/jgc.2021.21.e40
  contributor:
    fullname: Zhou
– volume: 271
  start-page: 120716
  year: 2021
  ident: key20230810105114_b192-ijmm-52-2-05272
  article-title: Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.120716
  contributor:
    fullname: Zheng
– volume: 190
  start-page: 881
  year: 2010
  ident: key20230810105114_b91-ijmm-52-2-05272
  article-title: Endogenous HMGB1 regulates autophagy
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200911078
  contributor:
    fullname: Tang
– volume: 214
  start-page: 105
  year: 2019
  ident: key20230810105114_b183-ijmm-52-2-05272
  article-title: siRNA therapeutics for breast cancer: Recent efforts in targeting metastasis, drug resistance, and immune evasion
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2019.08.005
  contributor:
    fullname: Ngamcherdtrakul
– volume: 13
  start-page: 544
  year: 2022
  ident: key20230810105114_b110-ijmm-52-2-05272
  article-title: Regulatory pathways and drugs associated with ferroptosis in tumors
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04927-1
  contributor:
    fullname: Wang
– volume: 36
  start-page: 109419
  year: 2021
  ident: key20230810105114_b27-ijmm-52-2-05272
  article-title: Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2021.109419
  contributor:
    fullname: Gaikwad
– volume: 13
  start-page: 116
  year: 2020
  ident: key20230810105114_b46-ijmm-52-2-05272
  article-title: HMGB1 in inflammation and cancer
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-00950-x
  contributor:
    fullname: Wang
– volume: 6
  start-page: 128
  year: 2021
  ident: key20230810105114_b129-ijmm-52-2-05272
  article-title: Pyroptosis: Mechanisms and diseases
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00507-5
  contributor:
    fullname: Yu
– volume: 113
  start-page: 2904
  year: 2022
  ident: key20230810105114_b159-ijmm-52-2-05272
  article-title: Oxidized high mobility group B-1 enhances metastability of colorectal cancer via modification of mesenchymal stem/stromal cells
  publication-title: Cancer Sci
  doi: 10.1111/cas.15400
  contributor:
    fullname: Kishi
– volume: 29
  start-page: 5299
  year: 2010
  ident: key20230810105114_b92-ijmm-52-2-05272
  article-title: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
  publication-title: Oncogene
  doi: 10.1038/onc.2010.261
  contributor:
    fullname: Tang
– volume: 11
  start-page: 1841
  year: 2021
  ident: key20230810105114_b20-ijmm-52-2-05272
  article-title: Flavonoids synergistically enhance the anti-glioblastoma effects of chemotherapeutic drugs
  publication-title: Biomolecules
  doi: 10.3390/biom11121841
  contributor:
    fullname: Zhai
– volume: 2010
  start-page: 915234
  year: 2010
  ident: key20230810105114_b45-ijmm-52-2-05272
  article-title: The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail
  publication-title: J Biomed Biotechnol
  doi: 10.1155/2010/915234
  contributor:
    fullname: Gong
– volume: 35
  start-page: 830
  year: 2019
  ident: key20230810105114_b107-ijmm-52-2-05272
  article-title: Targeting ferroptosis to Iron out cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.04.002
  contributor:
    fullname: Hassannia
– volume: 49
  start-page: 11933
  year: 2022
  ident: key20230810105114_b164-ijmm-52-2-05272
  article-title: HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-022-07989-8
  contributor:
    fullname: Zhang
– volume: 11
  start-page: 1451
  year: 2021
  ident: key20230810105114_b30-ijmm-52-2-05272
  article-title: Interactions of HMGB Proteins with the Genome and the Impact on Disease
  publication-title: Biomolecules
  doi: 10.3390/biom11101451
  contributor:
    fullname: Voong
– volume: 10
  start-page: 383
  year: 2019
  ident: key20230810105114_b147-ijmm-52-2-05272
  article-title: Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1585-2
  contributor:
    fullname: Zhu
– volume: 136
  start-page: 1219
  year: 2016
  ident: key20230810105114_b84-ijmm-52-2-05272
  article-title: Xeroderma pigmentosum Group A promotes autophagy to facilitate cisplatin resistance in melanoma cells through the activation of PARP1
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2016.01.031
  contributor:
    fullname: Ge
– volume: 19
  start-page: 405
  year: 2019
  ident: key20230810105114_b117-ijmm-52-2-05272
  article-title: Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0149-1
  contributor:
    fullname: Friedmann Angeli
– volume: 99
  start-page: 403
  year: 2021
  ident: key20230810105114_b167-ijmm-52-2-05272
  article-title: Chronic stress promotes acute myeloid leukemia progression through HMGB1/NLRP3/IL-1β signaling pathway
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-020-02011-9
  contributor:
    fullname: Liu
– volume: 12
  start-page: 92
  year: 2022
  ident: key20230810105114_b195-ijmm-52-2-05272
  article-title: Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2021.08.012
  contributor:
    fullname: Fu
– volume: 7
  start-page: e1438109
  year: 2018
  ident: key20230810105114_b64-ijmm-52-2-05272
  article-title: High mobility group box 1 (HMGB1) acts as an 'alarmin' to promote acute myeloid leukaemia progression
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2018.1438109
  contributor:
    fullname: Yasinska
– volume: 16
  start-page: 2628
  year: 2020
  ident: key20230810105114_b142-ijmm-52-2-05272
  article-title: miRNA-based biomarkers, therapies, and resistance in Cancer
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.47203
  contributor:
    fullname: He
– volume: 24
  start-page: 471
  year: 2022
  ident: key20230810105114_b169-ijmm-52-2-05272
  article-title: Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-021-02716-4
  contributor:
    fullname: Wei
– volume: 25
  start-page: 181
  year: 2022
  ident: key20230810105114_b44-ijmm-52-2-05272
  article-title: Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
  publication-title: Angiogenesis
  doi: 10.1007/s10456-021-09819-0
  contributor:
    fullname: Kam
– volume: 73
  start-page: 2195
  year: 2016
  ident: key20230810105114_b104-ijmm-52-2-05272
  article-title: Mechanisms of ferroptosis
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-016-2194-1
  contributor:
    fullname: Cao
– volume: 33
  start-page: 672
  year: 2022
  ident: key20230810105114_b150-ijmm-52-2-05272
  article-title: DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc
  publication-title: Mamm Genome
  doi: 10.1007/s00335-022-09963-y
  contributor:
    fullname: Ren
– volume: 270
  start-page: 113783
  year: 2021
  ident: key20230810105114_b178-ijmm-52-2-05272
  article-title: Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2021.113783
  contributor:
    fullname: Wang
– volume: 20
  start-page: 101
  year: 2022
  ident: key20230810105114_b70-ijmm-52-2-05272
  article-title: miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer
  publication-title: World J Surg Oncol
  doi: 10.1186/s12957-022-02500-w
  contributor:
    fullname: Zhang
– volume: 31
  start-page: e1904197
  year: 2019
  ident: key20230810105114_b105-ijmm-52-2-05272
  article-title: Recent progress in ferroptosis inducers for cancer therapy
  publication-title: Adv Mater
  doi: 10.1002/adma.201904197
  contributor:
    fullname: Liang
– volume: 10
  start-page: 561936
  year: 2020
  ident: key20230810105114_b17-ijmm-52-2-05272
  article-title: Clinical perspective of FDA approved drugs with P-Glycoprotein inhibition activities for potential cancer therapeutics
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.561936
  contributor:
    fullname: Lai
– volume: 14
  start-page: 1462
  year: 2022
  ident: key20230810105114_b83-ijmm-52-2-05272
  article-title: Chemotherapy resistance: Role of mitochondrial and autophagic components
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14061462
  contributor:
    fullname: Bahar
– volume: 14
  start-page: 2155
  year: 2018
  ident: key20230810105114_b102-ijmm-52-2-05272
  article-title: HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport
  publication-title: Autophagy
  doi: 10.1080/15548627.2018.1501134
  contributor:
    fullname: Luo
– volume: 17
  start-page: 90
  year: 2022
  ident: key20230810105114_b168-ijmm-52-2-05272
  article-title: Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
  publication-title: Chin Med
  doi: 10.1186/s13020-022-00645-0
  contributor:
    fullname: Wei
– volume: 10
  start-page: 650
  year: 2019
  ident: key20230810105114_b130-ijmm-52-2-05272
  article-title: The role of pyroptosis in cancer: Pro-cancer or pro-'host'?
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1883-8
  contributor:
    fullname: Xia
– volume: 12
  start-page: 719694
  year: 2021
  ident: key20230810105114_b23-ijmm-52-2-05272
  article-title: Update and new insights on future cancer drug candidates from plant-based alkaloids
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.719694
  contributor:
    fullname: Tilaoui
– volume: 128
  start-page: 3341
  year: 2018
  ident: key20230810105114_b190-ijmm-52-2-05272
  article-title: Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
  publication-title: J Clin Invest
  doi: 10.1172/JCI99032
  contributor:
    fullname: Hassannia
– volume: 12
  start-page: 376
  year: 2013
  ident: key20230810105114_b109-ijmm-52-2-05272
  article-title: Oxidative stress and cancer: An overview
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2012.10.004
  contributor:
    fullname: Sosa
– volume: 71
  start-page: 418
  year: 2021
  ident: key20230810105114_b97-ijmm-52-2-05272
  article-title: Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy
  publication-title: Endocrine
  doi: 10.1007/s12020-020-02417-y
  contributor:
    fullname: Run
– volume: 9
  start-page: 1664
  year: 2020
  ident: key20230810105114_b48-ijmm-52-2-05272
  article-title: High mobility group Box 1 in human cancer
  publication-title: Cells
  doi: 10.3390/cells9071664
  contributor:
    fullname: Rapoport
– volume: 25
  start-page: 1339
  year: 2021
  ident: key20230810105114_b72-ijmm-52-2-05272
  article-title: Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Zhou
– volume: 54
  start-page: 91
  year: 2022
  ident: key20230810105114_b111-ijmm-52-2-05272
  article-title: The mechanism of HMGB1 secretion and release
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-022-00736-w
  contributor:
    fullname: Chen
– volume: 12
  start-page: 6332
  year: 2021
  ident: key20230810105114_b135-ijmm-52-2-05272
  article-title: Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1971502
  contributor:
    fullname: Shi
– volume: 23
  start-page: 7865
  year: 2022
  ident: key20230810105114_b26-ijmm-52-2-05272
  article-title: The C-terminal acidic tail modulates the anti-cancer properties of HMGB1
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23147865
  contributor:
    fullname: Borde
– volume: 37
  start-page: 2257
  year: 2019
  ident: key20230810105114_b13-ijmm-52-2-05272
  article-title: Moving from poly (ADP-Ribose) polymerase inhibition to targeting DNA repair and DNA damage response in cancer therapy
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.18.02050
  contributor:
    fullname: Gourley
– volume: 41
  start-page: 981
  year: 2021
  ident: key20230810105114_b193-ijmm-52-2-05272
  article-title: The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
  publication-title: Cancer Commun (Lond)
  doi: 10.1002/cac2.12194
  contributor:
    fullname: Meng
– volume: 278
  start-page: 16
  year: 2011
  ident: key20230810105114_b78-ijmm-52-2-05272
  article-title: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2010.07919.x
  contributor:
    fullname: Gialeli
– volume: 22
  start-page: 578
  year: 2022
  ident: key20230810105114_b50-ijmm-52-2-05272
  article-title: HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
  publication-title: BMC Cancer
  doi: 10.1186/s12885-022-09675-1
  contributor:
    fullname: Amornsupak
– volume: 10
  start-page: 254
  year: 2020
  ident: key20230810105114_b136-ijmm-52-2-05272
  article-title: Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-19-0672
  contributor:
    fullname: Erkes
– volume: 12
  start-page: 715824
  year: 2021
  ident: key20230810105114_b172-ijmm-52-2-05272
  article-title: The Ciji-Hua'ai-Baosheng II formula attenuates chemotherapy-induced anorexia in mice with H22 hepatocellular carcinoma
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.715824
  contributor:
    fullname: Xi
– volume: 49
  start-page: 740
  year: 2018
  ident: key20230810105114_b132-ijmm-52-2-05272
  article-title: The endotoxin delivery protein HMGB1 mediates Caspase-11-dependent lethality in sepsis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.08.016
  contributor:
    fullname: Deng
– volume: 8
  start-page: 685434
  year: 2021
  ident: key20230810105114_b116-ijmm-52-2-05272
  article-title: Protective effects of dexazoxane on rat ferroptosis in doxorubicin-induced cardiomyopathy through regulating HMGB1
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.685434
  contributor:
    fullname: Zhang
– volume: 67
  start-page: 1459
  year: 2004
  ident: key20230810105114_b86-ijmm-52-2-05272
  article-title: Cisplatin-induced apoptosis in Hep3B cells: Mitochondria-dependent and -independent pathways
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2003.12.013
  contributor:
    fullname: Kim
– volume: 78
  start-page: 1017
  year: 2018
  ident: key20230810105114_b145-ijmm-52-2-05272
  article-title: miR-204-5p and miR-211-5p Contribute to BRAF inhibitor resistance in melanoma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-1318
  contributor:
    fullname: Díaz-Martínez
– volume: 37
  start-page: 205
  year: 2018
  ident: key20230810105114_b25-ijmm-52-2-05272
  article-title: HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0883-3
  contributor:
    fullname: Guo
– volume: 10
  start-page: 996307
  year: 2022
  ident: key20230810105114_b189-ijmm-52-2-05272
  article-title: HMGB1 is a mediator of cuproptosis-related sterile inflammation
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2022.996307
  contributor:
    fullname: Liu
– volume: 40
  start-page: 348
  year: 2021
  ident: key20230810105114_b151-ijmm-52-2-05272
  article-title: Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-02143-x
  contributor:
    fullname: Li
– volume: 23
  start-page: 2496
  year: 2022
  ident: key20230810105114_b5-ijmm-52-2-05272
  article-title: Cancer stem cells in ovarian cancer-a source of tumor success and a challenging target for novel therapies
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23052496
  contributor:
    fullname: Wilczyński
– volume: 70
  start-page: 1280
  year: 2019
  ident: key20230810105114_b123-ijmm-52-2-05272
  article-title: Sorafenib induces pyroptosis in macrophages and triggers natural killer cell-mediated cytotoxicity against hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.30666
  contributor:
    fullname: Hage
– volume: 36
  start-page: 1664
  year: 2022
  ident: key20230810105114_b101-ijmm-52-2-05272
  article-title: Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells
  publication-title: Phytother Res
  doi: 10.1002/ptr.7385
  contributor:
    fullname: Chen
– volume: 27
  start-page: 91
  year: 2007
  ident: key20230810105114_b141-ijmm-52-2-05272
  article-title: MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2007.06.017
  contributor:
    fullname: Grimson
– volume: 265
  start-page: 113302
  year: 2021
  ident: key20230810105114_b174-ijmm-52-2-05272
  article-title: Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2020.113302
  contributor:
    fullname: Ming
– volume: 110
  start-page: 528
  year: 2019
  ident: key20230810105114_b67-ijmm-52-2-05272
  article-title: MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.057
  contributor:
    fullname: Ding
– volume: 306
  start-page: 25
  year: 2019
  ident: key20230810105114_b94-ijmm-52-2-05272
  article-title: Polychlorinated biphenyl quinone-induced signaling transition from autophagy to apoptosis is regulated by HMGB1 and p53 in human hepatoma HepG2 cells
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2019.02.002
  contributor:
    fullname: Shi
– volume: 53
  start-page: 100715
  year: 2020
  ident: key20230810105114_b12-ijmm-52-2-05272
  article-title: Tumor micro-environment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
  publication-title: Drug Resist Updat
  doi: 10.1016/j.drup.2020.100715
  contributor:
    fullname: Erin
– volume: 14
  start-page: 406
  year: 2018
  ident: key20230810105114_b127-ijmm-52-2-05272
  article-title: Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.23542
  contributor:
    fullname: Wang
– volume: 181
  start-page: 1351
  year: 2021
  ident: key20230810105114_b157-ijmm-52-2-05272
  article-title: Evaluation of gender inequity in thyroid cancer diagnosis: Differences by Sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy
  publication-title: JAMA Internal Med
  doi: 10.1001/jamainternmed.2021.4804
  contributor:
    fullname: LeClair
– volume: 510
  start-page: 278
  year: 2019
  ident: key20230810105114_b112-ijmm-52-2-05272
  article-title: The release and activity of HMGB1 in ferroptosis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2019.01.090
  contributor:
    fullname: Wen
– volume: 2020
  start-page: 4751349
  year: 2020
  ident: key20230810105114_b175-ijmm-52-2-05272
  article-title: Baicalin ameliorates cognitive impairment and protects microglia from LPS-induced neuroinflammation via the SIRT1/HMGB1 pathway
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2020/4751349
  contributor:
    fullname: Li
– volume: 7
  start-page: 42
  year: 2019
  ident: key20230810105114_b56-ijmm-52-2-05272
  article-title: Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0511-6
  contributor:
    fullname: Gao
– volume: 5
  start-page: 15085
  year: 2015
  ident: key20230810105114_b81-ijmm-52-2-05272
  article-title: HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
  publication-title: Sci Rep
  doi: 10.1038/srep15085
  contributor:
    fullname: Zhou
– volume: 1799
  start-page: 101
  year: 2010
  ident: key20230810105114_b28-ijmm-52-2-05272
  article-title: HMGB proteins: Interactions with DNA and chromatin
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagrm.2009.09.008
  contributor:
    fullname: Stros
– volume: 11
  start-page: 6352
  year: 2020
  ident: key20230810105114_b43-ijmm-52-2-05272
  article-title: An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-20260-7
  contributor:
    fullname: Wang
– volume: 85
  start-page: 162
  year: 2017
  ident: key20230810105114_b98-ijmm-52-2-05272
  article-title: HMGB1/RAGE axis promotes autophagy and protects keratinocytes from ultraviolet radiation-induced cell death
  publication-title: J Dermatol Sci
  doi: 10.1016/j.jdermsci.2016.12.011
  contributor:
    fullname: Mou
– volume: 17
  start-page: 4083
  year: 2021
  ident: key20230810105114_b148-ijmm-52-2-05272
  article-title: Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation
  publication-title: Autophagy
  doi: 10.1080/15548627.2021.1901204
  contributor:
    fullname: Luo
– volume: 6
  start-page: 1181
  year: 2010
  ident: key20230810105114_b90-ijmm-52-2-05272
  article-title: The redox protein HMGB1 regulates cell death and survival in cancer treatment
  publication-title: Autophagy
  doi: 10.4161/auto.6.8.13367
  contributor:
    fullname: Tang
– volume: 22
  start-page: 46
  year: 2023
  ident: key20230810105114_b188-ijmm-52-2-05272
  article-title: Cuproptosis: Mechanisms and links with cancers
  publication-title: Mol Cancer
  doi: 10.1186/s12943-023-01732-y
  contributor:
    fullname: Xie
– volume: 1872
  start-page: 188310
  year: 2019
  ident: key20230810105114_b9-ijmm-52-2-05272
  article-title: Mechanisms of acquired tumor drug resistance
  publication-title: Biochim Biophys Acta Rev Cancer
  doi: 10.1016/j.bbcan.2019.188310
  contributor:
    fullname: Aleksakhina
– volume: 10
  start-page: 193
  year: 2019
  ident: key20230810105114_b126-ijmm-52-2-05272
  article-title: Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1441-4
  contributor:
    fullname: Yu
– volume: 30
  start-page: 431
  year: 2022
  ident: key20230810105114_b155-ijmm-52-2-05272
  article-title: circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2021.08.027
  contributor:
    fullname: Li
– volume: 60
  start-page: 8018
  year: 2021
  ident: key20230810105114_b121-ijmm-52-2-05272
  article-title: Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: Prospects for cancer therapy
  publication-title: Angew Chem Int Ed Engl
  doi: 10.1002/anie.202010281
  contributor:
    fullname: Wu
– volume: 7
  start-page: 255
  year: 2021
  ident: key20230810105114_b149-ijmm-52-2-05272
  article-title: Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer
  publication-title: Cell Death Discov
  doi: 10.1038/s41420-021-00649-z
  contributor:
    fullname: Lu
– volume: 20
  start-page: 151
  year: 2020
  ident: key20230810105114_b139-ijmm-52-2-05272
  article-title: Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies
  publication-title: Expert Rev Mol Diagn
  doi: 10.1080/14737159.2019.1665998
  contributor:
    fullname: Zeuschner
– volume: 80
  start-page: 2075
  year: 2020
  ident: key20230810105114_b186-ijmm-52-2-05272
  article-title: Targeting chromosomal architectural HMGB proteins could be the next frontier in cancer therapy
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-3066
  contributor:
    fullname: Mukherjee
– volume: 190
  start-page: 1
  year: 2016
  ident: key20230810105114_b170-ijmm-52-2-05272
  article-title: The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2016.05.055
  contributor:
    fullname: Xi
– volume: 5
  start-page: 159
  year: 2020
  ident: key20230810105114_b134-ijmm-52-2-05272
  article-title: GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-00274-9
  contributor:
    fullname: Peng
– volume: 20
  start-page: 428
  year: 2022
  ident: key20230810105114_b191-ijmm-52-2-05272
  article-title: Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
  publication-title: J Nanobiotechnol
  doi: 10.1186/s12951-022-01635-y
  contributor:
    fullname: Kim
– volume: 19
  start-page: 539
  year: 2014
  ident: key20230810105114_b47-ijmm-52-2-05272
  article-title: High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2014.01.014
  contributor:
    fullname: Huebener
– volume: 71
  start-page: 1277
  year: 2022
  ident: key20230810105114_b14-ijmm-52-2-05272
  article-title: Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
  publication-title: Gut
  doi: 10.1136/gutjnl-2021-324420
  contributor:
    fullname: Sundar
– volume: 58
  start-page: 500
  year: 2019
  ident: key20230810105114_b69-ijmm-52-2-05272
  article-title: HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22944
  contributor:
    fullname: Qian
– volume: 291
  start-page: 120268
  year: 2022
  ident: key20230810105114_b185-ijmm-52-2-05272
  article-title: miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2021.120268
  contributor:
    fullname: Sharma
– volume: 32
  start-page: 363
  year: 2013
  ident: key20230810105114_b73-ijmm-52-2-05272
  article-title: Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
  publication-title: Oncogene
  doi: 10.1038/onc.2012.49
  contributor:
    fullname: van Beijnum
– volume: 41
  start-page: e108272
  year: 2022
  ident: key20230810105114_b87-ijmm-52-2-05272
  article-title: Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance
  publication-title: EMBO J
  doi: 10.15252/embj.2021108272
  contributor:
    fullname: Çoku
– volume: 12
  start-page: 858
  year: 2021
  ident: key20230810105114_b160-ijmm-52-2-05272
  article-title: Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-021-04150-4
  contributor:
    fullname: Ren
– volume: 37
  start-page: 443
  year: 2020
  ident: key20230810105114_b8-ijmm-52-2-05272
  article-title: Acquired resistance to immune checkpoint inhibitors
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.03.017
  contributor:
    fullname: Schoenfeld
– volume: 42
  start-page: 301
  year: 2021
  ident: key20230810105114_b173-ijmm-52-2-05272
  article-title: Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/s41401-020-0478-3
  contributor:
    fullname: Li
– volume: 11
  start-page: 214
  year: 2015
  ident: key20230810105114_b88-ijmm-52-2-05272
  article-title: Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy
  publication-title: Autophagy
  doi: 10.4161/15548627.2014.994400
  contributor:
    fullname: Yang
– volume: 33
  start-page: e2104779
  year: 2021
  ident: key20230810105114_b194-ijmm-52-2-05272
  article-title: Cation-free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy
  publication-title: Adv Mater
  doi: 10.1002/adma.202104779
  contributor:
    fullname: Jiang
– volume: 575
  start-page: 299
  year: 2019
  ident: key20230810105114_b6-ijmm-52-2-05272
  article-title: A view on drug resistance in cancer
  publication-title: Nature
  doi: 10.1038/s41586-019-1730-1
  contributor:
    fullname: Vasan
– volume: 52
  start-page: e8657
  year: 2019
  ident: key20230810105114_b95-ijmm-52-2-05272
  article-title: Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells
  publication-title: Braz J Med Biol Res
  doi: 10.1590/1414-431x20198657
  contributor:
    fullname: Shi
– volume: 66
  start-page: 202
  year: 2016
  ident: key20230810105114_b62-ijmm-52-2-05272
  article-title: Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer
  publication-title: Pathol Int
  doi: 10.1111/pin.12393
  contributor:
    fullname: Lee
– volume: 15
  start-page: 179
  year: 2022
  ident: key20230810105114_b21-ijmm-52-2-05272
  article-title: Anticancer effects of ginsenoside Rh2: A systematic review
  publication-title: Curr Mol Pharmacol
  contributor:
    fullname: He
– volume: 11
  start-page: 986
  year: 2019
  ident: key20230810105114_b93-ijmm-52-2-05272
  article-title: Morin hydrate reverses cisplatin resistance by impairing PARP1/HMGB1-dependent autophagy in hepatocellular carcinoma
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers11070986
  contributor:
    fullname: Singh
– volume: 365
  start-page: 357
  year: 2016
  ident: key20230810105114_b77-ijmm-52-2-05272
  article-title: Mesenchymal-epithelial signalling in tumour microenvironment: Role of high-mobility group Box 1
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-016-2389-7
  contributor:
    fullname: Sharma
– volume: 40
  start-page: 45
  year: 2021
  ident: key20230810105114_b96-ijmm-52-2-05272
  article-title: MiR-451 promotes cell apoptosis and inhibits autophagy in pediatric acute myeloid leukemia by targeting HMGB1
  publication-title: J Environ Pathol Toxicol Oncol
  doi: 10.1615/JEnvironPatholToxicolOncol.2021037139
  contributor:
    fullname: Zhang
– volume: 54
  start-page: fpage
  year: 2022
  ident: key20230810105114_b158-ijmm-52-2-05272
  article-title: HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer
  publication-title: Acta Biochim Biophys Sin (Shanghai)
  doi: 10.3724/abbs.2022023
  contributor:
    fullname: Lei
– volume: 14
  start-page: 57
  year: 2017
  ident: key20230810105114_b4-ijmm-52-2-05272
  article-title: Combine and conquer: Challenges for targeted therapy combinations in early phase trials
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2016.96
  contributor:
    fullname: Lopez
– volume: 18
  start-page: 452
  year: 2018
  ident: key20230810105114_b18-ijmm-52-2-05272
  article-title: Revisiting the role of ABC transporters in multidrug-resistant cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0005-8
  contributor:
    fullname: Robey
– volume: 40
  start-page: 350
  year: 2021
  ident: key20230810105114_b119-ijmm-52-2-05272
  article-title: PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-02168-2
  contributor:
    fullname: You
– volume: 11
  start-page: 4561
  year: 2020
  ident: key20230810105114_b131-ijmm-52-2-05272
  article-title: Indirect regulation of HMGB1 release by gasdermin D
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18443-3
  contributor:
    fullname: Volchuk
– volume: 70
  start-page: 72
  year: 2015
  ident: key20230810105114_b80-ijmm-52-2-05272
  article-title: Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2015.01.013
  contributor:
    fullname: Yao
– volume: 20
  start-page: 149
  year: 2021
  ident: key20230810105114_b153-ijmm-52-2-05272
  article-title: Circular RNAs in acute myeloid leukemia
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01446-z
  contributor:
    fullname: Singh
– volume: 10
  start-page: 7775
  year: 2020
  ident: key20230810105114_b120-ijmm-52-2-05272
  article-title: Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant head and neck cancer cells to ferroptosis
  publication-title: Theranostics
  doi: 10.7150/thno.46903
  contributor:
    fullname: Lee
– volume: 304
  start-page: 120727
  year: 2022
  ident: key20230810105114_b184-ijmm-52-2-05272
  article-title: HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2022.120727
  contributor:
    fullname: Sharma
– volume: 7
  start-page: 121
  year: 2022
  ident: key20230810105114_b137-ijmm-52-2-05272
  article-title: Targeting non-coding RNAs to overcome cancer therapy resistance
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-022-00975-3
  contributor:
    fullname: Chen
– volume: 357
  start-page: 527
  year: 2015
  ident: key20230810105114_b75-ijmm-52-2-05272
  article-title: High-mobility group box 1: A novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.12.012
  contributor:
    fullname: Zhu
– volume: 6
  start-page: 421
  year: 2021
  ident: key20230810105114_b37-ijmm-52-2-05272
  article-title: An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00801-2
  contributor:
    fullname: Wei
– volume: 11
  start-page: 91
  year: 2008
  ident: key20230810105114_b74-ijmm-52-2-05272
  article-title: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
  publication-title: Angiogenesis
  doi: 10.1007/s10456-008-9093-5
  contributor:
    fullname: van Beijnum
– volume: 476
  start-page: 1729
  year: 2021
  ident: key20230810105114_b29-ijmm-52-2-05272
  article-title: The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-020-04015-y
  contributor:
    fullname: Wen
– volume: 13
  start-page: 16178
  year: 2021
  ident: key20230810105114_b36-ijmm-52-2-05272
  article-title: GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells
  publication-title: Aging
  doi: 10.18632/aging.203145
  contributor:
    fullname: Liu
– volume: 186
  start-page: 106514
  year: 2022
  ident: key20230810105114_b10-ijmm-52-2-05272
  article-title: Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2022.106514
  contributor:
    fullname: Xie
– volume: 6
  start-page: 2209
  year: 2016
  ident: key20230810105114_b180-ijmm-52-2-05272
  article-title: Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma
  publication-title: Theranostics
  doi: 10.7150/thno.15584
  contributor:
    fullname: Roy
– volume: 11
  start-page: 1580
  year: 2019
  ident: key20230810105114_b140-ijmm-52-2-05272
  article-title: Current concepts of Non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers11101580
  contributor:
    fullname: Barth
SSID ssj0025498
Score 2.4318223
Snippet Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1
SubjectTerms Amino acids
Apoptosis
Apoptosis - genetics
Autophagy
Autophagy - genetics
Breast cancer
Cancer
Cancer therapies
Care and treatment
Cell Death
Chemotherapy
Chromosomal proteins
Development and progression
DNA damage
Drug resistance
Drug resistance in microorganisms
Ferroptosis
Genes
Health aspects
HMGB1 Protein - genetics
Homeostasis
Humans
Immunotherapy
Inflammation
Leukemia
Liver cancer
Metastasis
Mitochondrial DNA
Multidrug resistant organisms
Natural products
Neoplasms - drug therapy
Neoplasms - genetics
Oncology, Experimental
Proteins
Review
RNA
Tumorigenesis
Tumors
Title Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)
URI https://www.ncbi.nlm.nih.gov/pubmed/37387415
https://www.proquest.com/docview/2848086864
https://pubmed.ncbi.nlm.nih.gov/PMC10373125
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTtwwcFRAqrhUbeljKUU-IAGHlMSxneRUQQVdVcoKIZD2ZiV-tFtpE7oPvr8ziRdID70l8khOZux5PwCO4pobnlQ03EVWkfCFiGqX8agi3bRQvigq8neUEzW-Ez-mchocbsuQVrnhiR2jtq0hH_kZstEc1e9cia_3fyKaGkXR1TBCYwt2Eh4rSunKpk8GF9o-XSlcQr64TKq-aSOKaH42-z2nOnSefpE84wOh9C9rfiabhnmTzwTR1Wt4FTRIdt6T_A28cM1beFmGGPke3JSOqnlny_mSzRrkPg_O4gNDTY-Ny-8XCZu3NgztYq1nq_W8XbAusdAu1j8Z2t-kU-JhYCd95OD0HdxdXd5-G0dhckJkRK5WkcyoQNWa3MSuzmpFbf6cTHzmVKGMFTZ1QsQ-8cZRh0DFvTWV8zEK75p7tGDew3bTNu4jMISpuBV4VVHY56mrjeQ1Rd-sLKqU-xEcb1Cn7_sGGRoNC0KyJiRrQrImJCMkYVbTzUH0mSoUAOA-1INKnyNfFmj9pPEIDgaQeOLNcHlDGx1u3FI_nY8RfOjJ9Pg91L2JNKcR5AMCPgJQj-3hSjP71fXapjJK_HW5__89P8Eu_WefGXgA26vF2n1GbWVVH3ZH8hB2Li4n1zf4Nrku_wJ9--rR
link.rule.ids 230,315,783,787,888,12068,21400,27936,27937,31731,33756,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RVqK9ICgtLBTwAQl6SJs4tpOcUItattCsUNVKvVmJH7CVNin74Pczs_EuDQdukTyS47E9D8_MNwDv45obnlTU3EVWkfCFiGqX8agi27RQvigqeu8oR2p4I77eytvw4DYLaZUrmbgU1LY19EZ-jGI0R_M7V-LT_a-IukZRdDW00NiALYKqQudr6_Rs9P1q7XKh97MshkvoNS6TqoNtRCXNj8d3E6pE5-mR5BnvqaV_hfMD7dTPnHygis6fwpNgQ7KTbtOfwSPX7MLjMkTJn8NV6aiedzybzNi4Qfnz21n8YGjrsWH55TRhk9aGtl2s9Wy-mLRTtkwttNPFD4YeOFmVeBzYxy52cLgHN-dn15-HUeidEBmRq3kkMypRtSY3sauzWhHQn5OJz5wqlLHCpk6I2CfeOMIIVNxbUzkfo_quuUcfZh82m7ZxL4EhTcWtwMuK6j5PXW0kryn-ZmVRpdwP4MOKdfq-g8jQ6FoQkzUxWROTNTEZKYmzmu4Oss9UoQQA5yEUKn2Cklmg_5PGAzjoUeKZN_3h1d7ocOdm-u8JGcCLbpvW_0P4TWQ7DSDvbeCagFC2-yPN-OcSbZsKKXHp8tX_53wH28Pr8lJfXoy-vYYdWnOXJ3gAm_Ppwr1B22Vevw0H9A_GleyB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJ028oAEDCgP8gDT2EJo4tpM8TRusFFiraWLS3qzEH1CkJqMf-_t317hl4YG3SLbk-Hy-D9_d7wDexxU3PCmpuYssI-ELEVUu41FJtmmhfFGU9N4xnqjRlfh2La9D_tMipFVuZOJaUNvG0Bv5AMVojuZ3rsTAh7SIi8_D45s_EXWQokhraKfxEHYyodK4BzunZ5OLy637hZ7QujAuoZe5TKoWwhEVNh9Mf8-oKp2nHyXPeEdF_Suo72mqbhblPbU03IPHwZ5kJy0DPIEHrn4Ku-MQMX8Gl2NHtb3TxWzBpjXKoltn8YOh3cdG4y-nCZs1NrTwYo1ny9WsmbN1mqGdr34y9MbJwkTWYB_aOMLRPlwNz358GkWhj0JkRK6WkcyoXNWa3MSuyipFoH9OJj5zqlDGCps6IWKfeOMIL1Bxb03pfIyqvOIe_Znn0Kub2r0EhnNKbgVeXFT9eeoqI3lFsTgrizLlvg-HG9LpmxYuQ6ObQUTWRGRNRNZEZJxJlNV0j5B8pgzlALgOIVLpE5TSAn2hNO7DQWcm8r_pDm_ORof7t9B_uaUPL9pj2v4PYTmRHdWHvHOA2wmEuN0dqae_1sjbVFSJW5ev_r_mO9hF3tTnXyffX8Mj2nKbMngAveV85d6gGbOs3gb-vAPF-vCv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+involved+in+the+HMGB1+modulation+of+tumor+multidrug+resistance+%28Review%29&rft.jtitle=International+journal+of+molecular+medicine&rft.au=Shao%2C+Li-Hua&rft.au=Zhu%2C+Li&rft.au=Wang%2C+Meng&rft.au=Ning%2C+Yue&rft.date=2023-08-01&rft.pub=D.A.+Spandidos&rft.issn=1107-3756&rft.eissn=1791-244X&rft.volume=52&rft.issue=2&rft_id=info:doi/10.3892%2Fijmm.2023.5272&rft_id=info%3Apmid%2F37387415&rft.externalDBID=PMC10373125
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1107-3756&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1107-3756&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1107-3756&client=summon